H. Lundbeck, Interim report for the second quarter of 2006

The Supervisory Board of H. Lundbeck A/S today approved the Group's interim report for the second quarter of 2006, which in line with the previous quarter was adversely affected by Forest Laboratories, Inc. reduction of in-house escitalopram inventories in 2006.